DOI: 10.1159/000087136. Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy

Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy

10.1159/000087136

Crossref journal-article

S. Karger AG

Oncology Research and Treatment (127)

Bibliography

Stahl, M., MÃ¼ller, C., KÃ¶ster, W., & Wilke, H. (2005). Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy. Oncology Research and Treatment, 28(10), 499â502. Portico.

Authors 4

Michael Stahl (first)
Christian Müller (additional)
Wolf Köster (additional)
Hansjochen Wilke (additional)

References 0 Referenced 8

None

Dates

Type	When
Created	19 years, 11 months ago (Sept. 19, 2005, 5:26 a.m.)
Deposited	4 months, 1 week ago (April 23, 2025, 11:19 p.m.)
Indexed	4 months, 1 week ago (April 25, 2025, 12:09 a.m.)
Issued	20 years, 8 months ago (Jan. 1, 2005)
Published	20 years, 8 months ago (Jan. 1, 2005)
Published Online	19 years, 11 months ago (Sept. 19, 2005)
Published Print	20 years, 8 months ago (Jan. 1, 2005)

Funders 0

None

BibTeX

@article{Stahl_2005, title={Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy}, volume={28}, ISSN={2296-5262}, url={http://dx.doi.org/10.1159/000087136}, DOI={10.1159/000087136}, number={10}, journal={Oncology Research and Treatment}, publisher={S. Karger AG}, author={Stahl, Michael and Müller, Christian and Köster, Wolf and Wilke, Hansjochen}, year={2005}, pages={499–502} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        4,
        25
      ]
    ],
    "date-time": "2025-04-25T04:09:34Z",
    "timestamp": 1745554174864,
    "version": "3.40.4"
  },
  "reference-count": 0,
  "publisher": "S. Karger AG",
  "issue": "10",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2005,
            1,
            1
          ]
        ],
        "date-time": "2005-01-01T00:00:00Z",
        "timestamp": 1104537600000
      },
      "content-version": "vor",
      "delay-in-days": 0,
      "URL": "https://www.karger.com/Services/SiteLicenses"
    },
    {
      "start": {
        "date-parts": [
          [
            2005,
            1,
            1
          ]
        ],
        "date-time": "2005-01-01T00:00:00Z",
        "timestamp": 1104537600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.karger.com/Services/SiteLicenses"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2005
      ]
    ]
  },
  "DOI": "10.1159/000087136",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        9,
        19
      ]
    ],
    "date-time": "2005-09-19T09:26:42Z",
    "timestamp": 1127122002000
  },
  "page": "499-502",
  "source": "Crossref",
  "is-referenced-by-count": 8,
  "title": "Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy",
  "prefix": "10.1159",
  "volume": "28",
  "author": [
    {
      "given": "Michael",
      "family": "Stahl",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Christian",
      "family": "M\u00fcller",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Wolf",
      "family": "K\u00f6ster",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Hansjochen",
      "family": "Wilke",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "127",
  "published-online": {
    "date-parts": [
      [
        2005,
        9,
        19
      ]
    ]
  },
  "container-title": "Oncology Research and Treatment",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://www.karger.com/Article/Pdf/87136",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.karger.com/Article/Pdf/87136",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2025,
        4,
        24
      ]
    ],
    "date-time": "2025-04-24T03:19:27Z",
    "timestamp": 1745464767000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://karger.com/article/doi/10.1159/000087136"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2005
      ]
    ]
  },
  "references-count": 0,
  "journal-issue": {
    "issue": "10",
    "published-online": {
      "date-parts": [
        [
          2005,
          9,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1159/000087136",
  "relation": {},
  "ISSN": [
    "2296-5270",
    "2296-5262"
  ],
  "subject": [],
  "container-title-short": "Oncol Res Treat",
  "published": {
    "date-parts": [
      [
        2005
      ]
    ]
  }
}